Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 33

Trial Status

Completed1
Terminated2
Other1

Role Distribution

Other Roles4

Activity Timeline

Research Network

Collaboration Network

8 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Arnoud Templeton, MD

Cantonal Hospital of St. Gallen

Moderately Similar
2 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer+1 more

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score44%

Roger von Moos, PD MD

Kantonsspital GraubĂ¼nden

Moderately Similar
1 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Andreas MĂ¼ller, MD

Kantonsspital Winterthur KSW

Moderately Similar
1 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Richard Cathomas, MD

Kantonsspital GraubĂ¼nden

Related
4 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 2 trials
Similarity Score18%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Metastatic Prostate CancerProstate Cancer
Similarity Score12%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Prostate Cancer
Similarity Score12%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Metastatic Breast CancerMetastatic Prostate Cancer
Similarity Score12%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

Prostate CancerProstate Cancer Metastatic
Similarity Score12%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Metastatic Breast Cancer
Similarity Score6%

Kevin Volpp, MD, PhD

University of Pennsylvania

Related
12 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02933801Phase 2StudyChair

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Prostate CancerProstate Cancer Metastatic
Terminated
NCT02053311Phase 3StudyChair

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Prostate Cancer
Withdrawn
NCT02051218Phase 3StudyChair

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer
Terminated
NCT01707966Phase 3StudyChair

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Prostate Cancer
Completed

All 4 trials loaded